December 23, 2020. Montgomery County should only approve the abadonment of Ellsworth Dr. if they provide a surface other than artificial turf or other artificial rubber products.
Read More »On Health Policy
NCHR’s Public Comments on Breast Cancer Treatment for Premenopausal Women
December 7, 2020: We strongly recommend that clinical trials on breast cancer treatments should include pre-menopausal women.
Read More »Diana Zuckerman’s Public Health presentation at FDA MDUFA Meeting, October 27, 2020
October 27, 2020: MDUFA performance goals need to be more patient-centered by including specific metrics pertaining to safety and effectiveness, both pre-market and post-market, and improving patients and consumer advocates’ access to meet with FDA decision-making officials. That will help provide the safeguards that patients and consumers deserve.
Read More »Open Letter to Stephen M. Hahn, M.D., Commissioner of the Food and Drug Administration: #ProtectTheFDA
In September 2020, medical and public health experts wrote to the FDA
Commissioner to express concern about political influence on FDA’s COVID-19 vaccine
decision-making, saying it could potentially compromise scientific integrity and public trust. The
open letter called on Commissioner Hahn to ensure vaccine approvals remain independent,
transparent, data-driven, and free from partisan pressure, urging actions like consulting with
other scientific bodies before issuing emergency authorizations.
NCHR’s Comments on the Petition for Extension of Premarket Tobacco Product Application Filing Deadline from Keller and Heckman LLP
We strongly oppose the requested extension of the deadline for premarket tobacco product applications (PMTAs), and we urge the FDA to not grant this requested extension.
Read More »